ATG-041

N/A

Report date: 2022/01/21 16:27:17

Base Information

Drug NameATG-041
Drug Alias NameATG-041
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase Mer inhibitorsAXL receptor tyrosine kinase inhibitors
TargetsTyrosine-protein kinase MerAXL receptor tyrosine kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAntengene Corporation Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAntengene Corporation Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A